Current State and Future of Systemic Treatment for Elderly Patients With Head and Neck Cancer Undergoing Radiotherapy.
Zamani P et al. Head Neck. 2026
Transoral Robotic Surgery-Based Treatment Versus Definitive Chemoradiation for Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zamani R et al. Head Neck. 2026
Association of Intratumoral Microbiota with Prognosis in Head and Neck Squamous Cell Carcinoma.
Yin S et al. Clin Cancer Res. 2026
Intravenous amivantamab after cetuximab failure in recurrent or metastatic head and neck squamous cell carcinoma: a single-centre retrospective real-world cohort study.
Xue L et al. Oral Oncol. 2026
Spatial transcriptomics of immune ecotypes for predicting immunotherapy outcomes in head and neck squamous cell carcinoma.
Xin Y et al. Oral Oncol. 2026
Safety and Efficacy of Endoscopic Thyroidectomy by Gasless Unilateral Axillary for Papillary Thyroid Carcinoma in Primary Hospitals.
Wu K et al. Head Neck. 2026
Stellate Ganglion Blockade for Acute Pain Management After Transoral Robotic Surgery.
Wong EC et al. Laryngoscope. 2026
Long-term swallowing outcomes following transoral robotic surgery for oropharyngeal cancer - Five years and beyond.
Wojtera BP et al. Oral Oncol. 2026
The Hidden Hazards of Vaping.
Usman AF et al. Laryngoscope. 2026
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer.
Truong AA et al. Head Neck. 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma.
Truong AA et al. Laryngoscope. 2026
An agentic framework for autonomous scientific discovery in cancer pathology.
Trost F et al. Nat Med. 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.
Xu C et al. Clin Cancer Res. 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.
Prasad M et al. Clin Cancer Res. 2026
Development of the TORS severe outcome score: a preoperative risk stratification tool for postoperative morbidity in oropharyngeal cancer.
Khaderi IM et al. Oral Oncol. 2026
Effect of Smoking in Oropharyngeal Cancer Treated With TORS: Systematic Review and Meta-Analysis.
Tong JY et al. Laryngoscope. 2026
T1 Microscopic Oropharyngeal Carcinoma: Revealing the Unknown Primary Through Diagnostic TORS.
Holsinger FC et al. Head Neck. 2026
Transoral Robotic Surgery (TORS) for Head and Neck Cancer in the Elderly Population: Functional Outcomes, Survival, and Complications.
Pamuk E et al. Head Neck. 2026
Transoral Robotic Surgery (TORS) Versus Open Surgery for Recurrent Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Laxague F et al. Head Neck. 2026
Interventional Radiotherapy (Brachytherapy) for the Treatment of the Primary Lesion in Squamous Cell Carcinomas of the Oral Vestibule.
Tondo A et al. Head Neck. 2026
Postoperative radiotherapy delineation after mandibular bone flap reconstruction in oral cavity and oropharyngeal cancers.
Thariat J et al. Oral Oncol. 2026
Behavioral Risk Factors and Seroprevalence for Human Papillomavirus in Sinonasal Carcinoma: A Multi-Institutional Case-Control Study.
Tanavde V et al. Head Neck. 2026
The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series.
Talwar A et al. Head Neck. 2026
Primary treatment modalities and p16 status in oropharyngeal squamous cell carcinoma outcomes: a tertiary center study with propensity score analysis.
Strojan P et al. Oral Oncol. 2026
Dermal Metastasis From Head and Neck Squamous Cell Carcinoma: Systematic Review and Pooled Analysis.
Stanisce L et al. Laryngoscope. 2026
Missed Opportunities: Laryngologists and Lung Cancer Screening in Early Glottic Cancer Patients.
Stack TJ et al. Laryngoscope. 2026
Transoral Robotic Resection of Pediatric Tongue Base Mucoepidermoid Carcinoma.
Somogyvári K et al. Laryngoscope. 2026
Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
So J et al. Int J Radiat Oncol Biol Phys. 2026
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial.
Hsu CH et al. Lancet Oncol. 2026
Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets.
Shah KD et al. Int J Radiat Oncol Biol Phys. 2026
Intraoperative Indocyanine Green Fluorescence Enables Primary Tumor Localization and Treatment De-Escalation in SCCUP: A Case Report.
Bellamkonda N et al. Head Neck. 2026
Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC.
Hose L et al. Br J Cancer. 2026
Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma.
Saykaly J et al. Head Neck. 2026
An Isolated Soft Tissue Ectopic Paraganglioma in the Head and Neck.
Sayeed S et al. Head Neck. 2026
Carcinoma of the parotid Gland: A Population-Based study of incidence and treatment outcomes in 1018 patients.
Sandström K et al. Oral Oncol. 2026
The prognostic significance of the 'Worst Pattern of Invasion' in oral cancers-an international collaborative multicentre analysis.
Roy P et al. Oral Oncol. 2026
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx.
Risch Z et al. Head Neck. 2026
Salvage surgery for residual and recurrent head and neck squamous cell carcinoma (RESCUE): An IReC multicentre consecutive cohort study.
Williamson A et al. Oral Oncol. 2026
Robotic-Assisted Extended Sistrunk Approach (RESA) for Salvage Surgery After Head and Neck Irradiation.
Wojtera B et al. Head Neck. 2026
High frequency of RB1 mutations p16 positive early stage oropharyngeal carcinoma: A genomic and transcriptomic analysis.
Brown MH et al. Oral Oncol. 2026
Refining the Multivariable Predictive-Prognostic PREDICTR-OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma.
Zhang LL et al. Laryngoscope. 2026
Postoperative Effects of Celecoxib on Opioid Use and Pain Control After Benign Oropharyngeal Surgery.
Platukus A et al. Laryngoscope. 2026
Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial.
Gauduchon T et al. Oral Oncol. 2026
Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT Scanner.
Radevic A et al. Head Neck. 2026
A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Fiedler M et al. Head Neck. 2026
Obstructive Sleep Apnea in Head and Neck Cancer Patients After Primary Treatment: A Review Focused on Oropharyngeal Cancer.
Patel N et al. Head Neck. 2026
The Application of Radiomics in Laryngeal Cancer Management: A Scoping Review of the Literature.
Papadopoulou AM et al. Laryngoscope. 2026
Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.
Palatnik B et al. Laryngoscope. 2026
Trend in Initial Management of T4 Laryngeal Squamous Cell Carcinoma.
Orr AJ et al. Head Neck. 2026
Smoking, Tumor Subsite, and Stage as Predictors of Second Primary Tumors in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Retrospective Cohort Study.
da Silva FMA et al. Head Neck. 2026